*Department of Ophthalmology and Visual Sciences

†Kellogg Eye Center and Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, U.S.A.

Accepted for publication August 2, 2023.

Supported by NIH, Bethesda, MD EY008976.

T.J.S. has been issued US patents covering the use of IGF-I receptor antagonists as therapy for autoimmune disease. These are held by UCLA/Lundquist Institute. He is consultant for Horizon, Veridian, Minghui, Lundbeck.

Address correspondence and reprint requests to Terry J. Smith, M.D., Department of Ophthalmology and Visual Science, Kellogg Eye Center, Michigan Medicine, 1000 Wall Street, Ann Arbor, MI 48105. E-mail: [email protected]